Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) Decides to Acquire Approx. KRW 100 Billion Worth of Treasury Shares, Outlining Post-Acquisition Retirement Plan

Posted on April 3, 2025July 15, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) Decides to Acquire Approx. KRW 100 Billion Worth of Treasury Shares, Outlining Post-Acquisition Retirement Plan

Source of Fact: Financial Supervisory Service DART / 2025-04-03

Disclosure Type: Decision on Acquisition of Treasury Shares

💡 3-Second Summary

Celltrion has decided to acquire approximately KRW 100 billion worth of treasury shares (589,276 shares) through on-market purchases to stabilize its stock price and enhance shareholder value, with plans to retire all acquired shares after the acquisition is completed.

📊 1. [Key Disclosure Content & Major Figures Summary]

Celltrion has officially resolved and disclosed its treasury share acquisition plan as follows:

  • Number of Shares to be Acquired: 589,276 common shares (No other share classes)
  • Estimated Acquisition Amount: KRW 100,000,137,200 (Calculated based on the closing price of KRW 169,700 on April 2, 2025, the day prior to the board resolution; the actual amount may vary depending on future share price fluctuations)
  • Expected Acquisition Period: April 4, 2025 ~ July 3, 2025
  • Purpose of Acquisition: Stock price stabilization and enhancement of shareholder value
  • Method of Acquisition: Direct on-market purchase through the KRX market
  • Entrusted Investment Brokers: NH Investment & Securities, Meritz Securities
  • Treasury Shares Held Prior to This Decision: 9,473,917 common shares (4,469,340 shares acquired within dividendable profits, 5,004,577 shares acquired via other methods)
  • Daily Buy Order Limit: 117,384 common shares
  • Other Details: The company plans to retire all acquired shares after the acquisition; the expected holding period is 6 months or more from the final acquisition date
  • Treasury Share Acquisition Limit Under Commercial Act: KRW 4,663,415,101,382 (Calculated based on the dividendable profit limit on the individual balance sheet as of December 31, 2024)

📈 2. [Expert’s Perspective: What This Disclosure Means for Investors]

This disclosure conveys the company’s plan to purchase its own shares on the open market and subsequently retire them. The transaction is designed as a direct on-market buyback, and the company intends to cancel all the shares acquired through this process.

Investors should note that the estimated acquisition amount of approximately KRW 100 billion is a projected figure based on the closing price from the day preceding the board meeting, meaning the final cash outlay may change depending on market conditions. It is also observable that this buyback decision was determined within the company’s legal limit for treasury share acquisitions, which is calculated at approximately KRW 4.66 trillion under the Commercial Act.

📝 Editor’s Comment (by K-STOCK Editor)

This disclosure explicitly outlines the company’s plan to execute a full retirement of the treasury shares following their acquisition. However, since this retirement is currently specified as a corporate plan rather than an immediately guaranteed event, investors should verify whether the actual retirement process is successfully executed after the buyback is completed.

The key parameter for investors to track in the near term is the actual execution rate of the buyback during the designated period from April 4 to July 3, 2025. Monitoring whether the purchase proceeds smoothly within the daily order limit through the appointed brokers, NH Investment & Securities and Meritz Securities, is the essential first step.

Furthermore, once the acquisition is finalized, investors should continuously check for subsequent disclosures to verify the actual execution of the planned retirement and the official updates regarding the final outstanding share count.

📢 Disclaimer & Source Information

Source: This content was structured and newly generated based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Advisory: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact us at ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) Signs Supply Contract Worth KRW 371,353,400,000 for Indian K9 Self-Propelled Howitzer Phase 2 Export Project
Next Post: [Disclosure] SK Hynix (000660) Designated as Short-Selling Overheated Stock: Comprehensive 1-Day Short-Selling Ban Enforced by KRX

Related Posts

[Disclosure] SK Hynix(000660) Finalizes Terms for KRW 40 Trillion Paid-in Capital Increase Linked to Nasdaq ADRs (Issued at 2.72% Premium) Disclosures
[Disclosure] Hanwha Aerospace (012450) Files Corporate Value Enhancement Plan, Maintaining KRW 11T Investment and DPS of KRW 3,500 or Higher Disclosures
[Disclosure] Celltrion (068270) Secures Final FDA Approval for ‘Omlyclo’, a Biosimilar of Xolair Disclosures
[Disclosure] Alteogen (196170) to List 28,055 Additional Common Shares via Preferred Stock Conversion Disclosures
[Disclosure] Samsung Biologics (207940) Sets Evaluated Price at KRW 1,221,000 for Relisting Following Corporate Division Bio & Healthcare
[Disclosure] Samsung Biologics (207940) Schedules Q3 2024 Earnings Release for October 23 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme